Resources

Minister for Skills Baroness Jacqui Smith chose Precision Health Technology Accelerator (PHTA) as the setting for the launch of a new Higher Technical Qualification (HTQ) designed to tackle the UK’s growing medtech skills shortage.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, today announced a further strengthening of its senior leadership with Ian Coyne joining the Managing Partners group. In addition to this strategic leadership expansion, the firm further refined the structure of its Senior Leadership team, with Joe Coulter assuming a new role as Chief Business Officer (CBO) and Charlotte James being promoted to Chief Operating Officer (COO).

Oxford Nanopore Technologies has appointed Francis Van Parys as Chief Executive Officer (CEO). Francis will join the Company and the Board as an Executive Director on 2 March 2026.

BIA thought leadership takes centre stage with two key reports published: last week saw the release of 'From innovation to impact: unlocking patient access to innovative rare disease medicines', and today 'UK cell and gene therapy: driving efficiencies and innovation' celebrates real-world UK success.

Meet the newly elected BIA Board members bringing fresh expertise to shape the future of life sciences.

Enedra Therapeutics appoints Adrian Ibrahim, PhD, MBA, as its new Chief Executive Officer. Dr Ibrahim will also join the Company’s Board of Directors.

Just one month after launch, five early-stage science companies have moved into the Leap incubator lab space at ARC West London. The first cohort of innovators joining Leap includes: Solveteq, Reseda Life Sciences, Tachmed, IgEDAPT, and Sea2Carbon.

BioPartner UK is delighted to announce the appointment of Nathalie Huther to its Advisory Board.

NRG Therapeutics, an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce expansion of its team with the appointment of Paul Thompson PhD as Chief Development Officer (CDO).

Senior leaders from PHTA and Clinical Immunology Services took home the top prizes in two prestigious categories at the West Midlands Innovation Awards

From stronger STEM foundations and digital/AI literacy in schools to clearer post-16 technical pathways and lifelong learning opportunities, these reforms offer a once-in-a-generation chance to prepare a workforce ready for the next wave of biotech innovation.

In this blog, Dr Kate Barclay, Skills Strategy Consultant at BIA, explores two pivotal developments — the National Curriculum review and Skills England’s AI Skills for the UK Workforce report — and what they mean for preparing the next generation of scientifically confident, AI-literate talent for biotech.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Slingshot Therapeutics Limited and is pleased to announce the placement of Dr John Isaac as Chief Scientific Officer.

Prokarium appoints Ibs Mahmood as Chief Executive Officer

PIR International recently partnered with a PE-backed pharmaceutical services company in appointing a Chief Growth Officer.

PIR International was delighted to partner with Slingshot Therapeutics on the appointment of Bobby Soni as Chief Business Officer.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Vicore Pharma Holding AB (STO: VICO) and is pleased to announce the placement of Katrine Husum as R&D Senior Project Director.

This blog explores the transformative BIA MAC Leadership Programme (LeaP) — a unique initiative empowering emerging bioprocessing professionals to accelerate their careers and strengthen leadership across the UK life sciences sector. With 76% of participants reporting career progression, LeaP is shaping the next generation of biotech leaders.

Research shows that while 85% of biopharma executives view partnerships as business-critical, around half report failure rates exceeding 60%. Baringa is on a mission to help life sciences organisations get partnering right.

From scaling up advanced therapy manufacturing to harnessing the power of digital and automation, Ed Samuel, the new COO of the CGT Catapult, discusses how collaboration and innovation will shape the next phase of the UK’s cell and gene therapy ecosystem.